Results 181 to 190 of about 69,008 (285)

Pathologic Complete Response Rates in Early-Stage Human Epidermal Growth Factor 2 (HER2)-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Anti-HER2 Therapy: A Real-World Experience. [PDF]

Cureus
Mokfi R, Boutaagount F, Maskrout M, Bennour S, Senoussi C, Nadif L, Berrada N, Lamine L, Bouhou I, Naciri S, Rais G.   +10 more
europepmc   +1 more source

Study of the Interaction of the Extracellular Domain in the ErbB2-ErbB2homodimer and ErbB2-Trastuzumab by Hydrodynamic Properties and Computational Models

, 2014
Javier Ramos, Juan F. Vega, Víctor L. Cruz, Ping Hu, Javier Cortés, Javier Martínez‐Salazar   +5 more
openalex   +1 more source

127TiP An open-label, randomized, multicenter, phase III study of trastuzumab deruxtecan (T-DXd) with bevacizumab (BEV) vs BEV monotherapy as first-line (1L) maintenance therapy in HER2-expressing ovarian cancer: DESTINY-Ovarian01 (DO 01)

A. González-Martín, Jo Marie Tran Janco, June‐Yong Lee, Domenica Lorusso, Sven Mahner, K.N. Moore, D.S. Tan, Veronica Mariotti, Jared H. Hara, Shao‐Ying Hua, J.F. Liu, Kazuki Hasegawa   +11 more
openalex   +2 more sources

Development and Characterization of Copaiba Oil‐Loaded Polymeric Nanocapsules With Enhanced Antitumor Activity Against Breast Cancer Cells

Particle &Particle Systems Characterization, Volume 43, Issue 1, January 2026.
The present study developed and characterized a novel copaiba oil polymeric nanoparticle (NPOC), which was efficiently internalized by breast cancer cells, exhibited greater cytotoxicity and selectivity than free copaiba oil and standard drug doxorubicin. NPOC also reduced tumor growth and migration in 3D models.
Karinne Kelly Gadelha Marques, Allesya Lara Dantas Formiga, Ramon Ramos Marques de Souza, Isione Oliveira Castro, Heivila Monique da Silva Alexandre, Igor Gabriel da Silva Ramalho, Érika Raisla Melquiades Pereira, Lucas Medeiros Martins Carvalho, Marianna Vieira Sobral, Francisco Humberto Xavier Júnior, Juan Carlos Ramos Gonçalves   +10 more
wiley   +1 more source

Prognostic and predictive significance of neutrophil/lymphocyte ratio for trastuzumab treatment efficacy in HER2-positive breast cancer. [PDF]

Sci Rep
Cao J, Pang J, Li Y, Wang S, Xiao Z, Ding N.   +5 more
europepmc   +1 more source

An anti-ErbB2 fully human antibody circumvents trastuzumab resistance

, 2016
Qiong Lu, Lingfei Wang, Yajun Zhang, Xiaojie Yu, Chao Wang, Huajing Wang, Yang� Yang, Xiaodan Chong, Tian Xia, Yanchun Meng, Yuxiao Wang, Cuihua Lu, Lijun Zhou, Bohua Li   +13 more
openalex   +2 more sources

Magnetically Retrievable Platinum Nanoreporters for Efficient Lateral Flow Immunoassay in Complex Bio‐Samples

Small, Volume 22, Issue 2, 8 January 2026.
Lateral flow immunoassays (LFIAs) for rapid, point‐of‐care testing face challenges with real patient samples. This work presents magnetically retrievable platinum nanoreporters for LFIAs that purify and concentrate samples, and amplify signals, enhancing sensitivity and lowering the visual limit of detection in complex bio‐samples such as human serum ...
Yuxi Cheng, Luca Panariello, Adam Creamer, Christy J. Sadler, André Shamsabadi, Kathleen Lupien, Ali Vaughan, Thomas Gervais, Molly M. Stevens   +8 more
wiley   +1 more source

HER2-Targeted Antibody-Drug Conjugate Toxicities in Breast Cancer. [PDF]

Cancer Med
Lee S, Kahn AM, Rozenblit M, George MA, Naranjo Ortiz C, Lustberg MB.   +5 more
europepmc   +1 more source

Future directions in the adjuvant treatment of breast cancer: The role of trastuzumab

, 2001
Ian Smith
openalex   +1 more source

Functionalizing Nucleic Acids: Synthesis and Purification Strategies for Bioconjugates as Biomaterials

Small, Volume 22, Issue 5, 22 January 2026.
Nucleic acid‐ligand conjugates combine the distinct properties of macromolecular ligands with the versatility of DNA/RNA nanotechnology. In biomaterial and nanomedicine applications, highly purified products are paramount, requiring reliable synthesis and purification methods.
Nico Alleva, Jian Zhang, David Y. W. Ng, Tanja Weil, Torsten John   +4 more
wiley   +1 more source